Recombinant Human PPIA Protein，His

The study of PPIA (Peptidyl-Prolyl Isomerase A), also known as cyclophilin A, has gained significant attention in the field of molecular biology due to its crucial role in protein folding and cellular regulation. PPIA is a member of the peptidyl-prolyl isomerase family, which facilitates the cis-trans isomerization of proline residues in polypeptides, thereby influencing protein conformation and activity. Beyond its fundamental biochemical actions, PPIA has been implicated in various physiological and pathological processes, including immune response, inflammation, and viral replication, particularly in relation to HIV-1, where it acts as a cofactor for the virus's life cycle. Additionally, PPIA has been linked to several disease states, including cancer, where its overexpression is associated with increased tumor growth and poor prognosis. Given its diverse biological functions and relevance to human health, researchers are focused on exploring the potential of PPIA as a therapeutic target. Recent advances in recombinant protein technology have enabled the production of PPIA in various expression systems, allowing for in-depth structural and functional studies. This research not only enhances our understanding of PPIA's multifaceted roles but also paves the way for the development of novel pharmacological interventions aimed at modulating its activity in disease settings.